FMP
XBiotech Inc.
XBIT
NASDAQ
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
6.38 USD
0.04 (0.627%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. John Simard
sector
Healthcare
industry
Biotechnology
website
https://www.xbiotech.comexchange
NASDAQ
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
CIK
0001626878
ISIN
CA98400H1029
CUSIP
98400H102
Address
5217 Winnebago Lane
Phone
512 386 2900
Country
US
Employee
82
IPO Date
Apr 15, 2015
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
XBIT Financial Summary
CIK
0001626878
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
98400H102
ISIN
CA98400H1029
Country
US
Price
6.38
Beta
1.41
Volume Avg.
50.72k
Market Cap
194.48M
Shares
-
52-Week
3.83-9.96
DCF
6.57
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-5.91
P/B
-
Website
https://www.xbiotech.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest XBIT News
It looks like there's no news available.
